Max Johnson, in vivo Drug Development
RDavila@mednet.ucla.edu
Max Johnson is a research associate working on pre-clinical studies in our Drug Development program. His scope of work involves identifying a combination of investigational therapies pre-clinically that may inform the design and execution of clinical trials, ultimately and hopefully leading to improvements in brain tumor patient outcomes.